Ken Griffin Certara, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$15.65 - $19.45 $145,545 - $180,885	-9,300 Reduced 54.39%	7,800 $139,000
Q4 2023 Feb 14, 2024	BUY	$12.12 - $18.19 $29,087 - $43,656	2,400 Added 16.33%	17,100 $300,000
Q3 2023 Nov 14, 2023	BUY	$13.9 - $19.58 $65,330 - $92,025	4,700 Added 47.0%	14,700 $213,000
Q2 2023 Aug 14, 2023	SELL	$16.89 - $24.64 $1,689 - $2,464	-100 Reduced 0.99%	10,000 $182,000
Q1 2023 May 15, 2023	BUY	$15.9 - $24.72 $17,490 - $27,192	1,100 Added 12.22%	10,100 $243,000

Q4 2022 Feb 14, 2023	SELL	$10.7 - $17.84 $90,950 - $151,640	-8,500 Reduced 48.57%	9,000 $144,000
Q3 2022 Nov 14, 2022	SELL	$12.84 - $24.13 $87,312 - $164,084	-6,800 Reduced 27.98%	17,500 $232,000

225

109M

7.8K

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $2.21B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.